InvestorBrandNetwork (IBN) logo

InvestorBrandNetwork (IBN)

The latest articles, editorials and news releases from InvestorBrandNetwork (IBN), a growing Investor Brand Platform.

RSS Feed for InvestorBrandNetwork (IBN)

Gold Makes Modest Gains from Recent Losses, Investors Await US Economic Data

September 30, 2026 — The price of gold recovered modestly on Tuesday to claw out of the near two-month low it had sunk to during the previous trading sessions. Investors are currently studying the Middle East situation while also watching out for a number of economic data releases that are due in the U.


2 Billion Pounds of Cancer-Causing Chemicals Found Their Way into America in 2020

September 30, 2026 — Chemicals suspected of raising the risk of breast cancer entered America’s air by the billions of pounds within one recent year, settling into a pattern that stretches across daily life. The exposure shows up in outdoor air, tap water, food, and the products sitting on household shelves, all traced back to the same body of research.


AINewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) QwikAgents Expands AI Platform With NVIDIA Support, Hermes Runtime

September 30, 2026 — Silo Pharma (NASDAQ: SILO) announced that its wholly owned managed AI agent subsidiary QwikAgents expanded its platform with support for customer-supplied NVIDIA API keys and the addition of Hermes agent runtime. Customers can use their own NVIDIA API keys to access NVIDIA Nemotron models, making NVIDIA the fifth supported bring-your-own-key provider alongside Anthropic, OpenAI, Google and DeepSeek.


InvestorNewsBreaks – VERAXA Biotech AG (NASDAQ: VRXA) Moves VXA-222 Bispecific ADC to Next Development Stage

September 29, 2026 — VERAXA Biotech (NASDAQ: VRXA) has advanced its VXA-222 bispecific antibody-drug conjugate (“ADC”) program beyond the initial discovery phase following the completion of its collaboration with OmniAb, with the company now planning to engineer the final candidate using its antibody-engineering, linker and conjugation technologies and conduct in vitro and in vivo preclinical studies. VXA-222 employs an “AND-gate” design intended to recognize two tumor-associated antigens simultaneously, potentially increasing selectivity for cancer cells, while VERAXA continues developing a broader oncology pipeline spanning ADCs, T-cell engagers and other engineered antibody formats.


Training Decay and the Need for Continuous, Scenario-Based Readiness

September 29, 2026 — Training decay can create challenges for public safety agencies as important skills and knowledge fade when they are not regularly reinforced. Continuous training can help personnel maintain proficiency and readiness between formal certification or qualification periods.


Top Possibilities of How AI Could Hypothetically Wipe Out Humanity

September 29, 2026 — Earlier this month, AI researcher Jacob Coxon left Anthropic after spending only four months at the company. In a post on X, Coxon warned that many people developing AI genuinely believe the technology could pose an existential threat to humanity before the decade ends.


Copper Prices Seem to Be Positioning for a Significant Upswing

September 29, 2026 — The price of copper appears to be building the foundation for another potentially significant advance, with the technical picture pointing to possibly higher prices, if the metal can overcome an important resistance level. The setup begins with a notable reversal in copper’s recent price action.